Clinical Trial Update: A Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B in France

View source ↗

Summary

This completed clinical trial evaluated the real-world effectiveness and usage of Alprolix in patients with Hemophilia B in France.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Alprolix (eftrenonacog alfa)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Haemophilia B | Status: COMPLETED